Schizophrenia: A neurodevelopmental disorder that affects millions of people's lives.

Schizophrenia is a chronic neurodevelopmental disorder that alters how an individual visualizes the world, thinks, behaves and feels. People with schizophrenia experience symptoms such as delusions, hallucinations, disorganized thinking, and disorganized behavior (Cleveland Clinic, 2022). This paper reviews the clinical symptomatology, severe danger and risks along with the outcome and effects of anosognosia on schizophrenic patients, analyzes effective clinical treatments, triggers that may affect schizophrenia, and examines research data regarding the disproportionately high suicide rates found in many schizophrenic patients.

Authors

Publication Details

Journal
Zenodo (CERN European Organization for Nuclear Research)
Published
2026-10-16
DOI
https://doi.org/10.5281/zenodo.23407008
Primary Topic
Schizophrenia research and treatment
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Schizophrenia: A neurodevelopmental disorder that affects millions of people's lives.

Asil Kattea
Zenodo (CERN European Organization for Nuclear Research)
Schizophrenia research and treatment
article

Schizophrenia: A neurodevelopmental disorder that affects millions of people's lives.

Asil Kattea
article en

Abstract

Schizophrenia is a chronic neurodevelopmental disorder that alters how an individual visualizes the world, thinks, behaves and feels. People with schizophrenia experience symptoms such as delusions, hallucinations, disorganized thinking, and disorganized behavior (Cleveland Clinic, 2022). This paper reviews the clinical symptomatology, severe danger and risks along with the outcome and effects of anosognosia on schizophrenic patients, analyzes effective clinical treatments, triggers that may affect schizophrenia, and examines research data regarding the disproportionately high suicide rates found in many schizophrenic patients.

Zenodo (CERN European Organization for Nuclear Research)
Good health and well-being
Openalex Percentile: Top 13%
Schizophrenia research and treatment
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.